Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants

Pediatric Infectious Disease Journal

Volumn 15, Issue 8, 1996, Pages 650-654

  Karron, Ruth A ^a,b   Makhene, Mamodikoe ^a   Gay, Kathleen ^a,b   Wilson, Modena H ^b   Clements, Mary Lou ^a,b   Murphy, Brian R ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

attenuated parainfluenza virus vaccine; attenuated vaccine; infant immunization; Parainfluenza vaccine; pediatric immunization; respiratory virus vaccine

Indexed keywords

LIVE VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INTRANASAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT INFECTION; PARAINFLUENZA VIRUS 3; PHASE 1 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RNA VIRUS INFECTION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; RESPIRATORY TRACT INFECTIONS; RESPIROVIRUS; RESPIROVIRUS INFECTIONS; VACCINATION; VIRAL VACCINES;

EID: 0029742064     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199608000-00003     Document Type: Article

References (17)

1. Chanock RM, McIntosh K. Parainfluenza viruses. In: Fields BN, Knipe DM, eds. Virology. 2nd ed. New York: Raven Press, 1990:963-88.
2. Chanock RM, Parrott RH, Johnson KM, Kapikian AZ, Bell IA. Myxoviruses: parainfluenza. Am Rev Respir Dis 1963;88: 152-66.
3. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973;288:498-505.
4. Parrott RH, Vargosko AJ, Kim HW, et al. Acute respiratory diseases of viral etiology: III. Myxoviruses: parainfluenza. Am J Public Health 1962;52:907-17.
5. Glezen WP, Frank AL, Taber LH, Kasel JA. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 1984;150:851-7.
6. Meissner HC, Murray SA, Kieman MA, Snydman DA, McIntosh K. Simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr 1984;104:680-4.
7. Karron RA, O'Brien KL, Froehlich JL, Brown VA. Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J Infect Dis 1993;167:1441-5.
8. Murphy BR, Hall SL, Kulkarni AB, et al. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res 1994;32:13-36.
9. Heilman CA. Respiratory syncytial and parainfluenza viruses. J Infect Dis 1990;161:402-6.
10. Karron RA, Wright PF, Hall SL, et al. A live attenuated bovine parainfluenza type 3 virus vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis 1995;171:1107-14.
11. Clements ML, Belshe RB, King J, et al. Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees. J Clin Microbiol 1991;29:1175-82.
12. Belshe RB, Karron RA, Newman FK, et al. Evaluation of a live attenuated cold-adapted parainfluenza virus type 3 vaccine in children. J Clin Microbiol 1992;30:2064-70.
13. Belshe RB, Hisson FK. Cold adaptation of parainfluenza virus type 3: induction of three phenotypic markers. J Med Virol 1982;10:235-42.
14. Karron RA, Wright PF, Newman FK, et al. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis 1995; 172:1445-50.
15. Murphy BR, Alling DW, Snyder M, et al. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 1986;24:894-8.
16. Karron RA, Steinhoff MC, Subbarao EK, et al. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. Pediatr Infect Dis J 1995;14:10-16.
17. Clements ML, Makhene MK, Karron RA, et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J Infect Dis 1996;173:44-51.